Payer HEOR Submission Analysis & Coverage Recommendation Framework
Analyze manufacturer HEOR submissions and generate evidence-based payer coverage recommendations
What You Can Do
You can rapidly extract and validate key claims from manufacturer HEOR dossiers (typically 200+ pages), assess cost-effectiveness calculations against payer willingness-to-pay thresholds, identify evidence gaps and potential bias, and generate formulary recommendations with documented rationale for P&T committee review. This framework reduces typical 3-5 hour manual analysis to 90 minutes of focused, traceable review.
Features
automatically identifies clinical efficacy claims, economic model assumptions, and comparative evidence from unstructured submissions
tests manufacturer calculations against standard payer thresholds and flags methodological concerns
surfaces missing comparators, underrepresented populations, and insufficient real-world data
flags selective outcome reporting, unfavorable comparator choice, and model parameter manipulation
translates findings into formulary tier placement, prior authorization criteria, or coverage policy language
generates decision memos with evidence grading and rationale for committee review
handles new drug approvals, indication expansions, biosimilar launches, and contract renewal scenarios
Example Output
Example 1: Cost-Effectiveness Review
- ICER Claim: $62,000/QALY vs. standard therapy
- Framework Output: Methodology sound. Model uses 10-year time horizon appropriate for chronic disease. Sensitivity analysis adequate. Within payer threshold ($75K). Recommend preferred tier. Risk: Manufacturer assumes 85% adherence; real-world data shows 62%. Recommend outcomes-based contract clause.
Example 2: Evidence Gap Identification
- Submission compares only to Drug A (poorly effective, off-patent)
- Missing: Comparison to Drug B (current preferred agent, same mechanism, similar cost)
- Missing: Subgroup efficacy data for patients with renal impairment (25% of target population)
- Framework Output: Insufficient evidence for broad coverage. Recommend limiting to treatment-naive patients pending comparative effectiveness vs. Drug B.
Example 3: Coverage Recommendation
- Drug: New GLP-1 agonist for Type 2 diabetes
- Framework Output: Recommended Coverage Policy: Tier 2 preferred. PA required if: patient BMI <30, HbA1c >10%, or prior GLP-1 failure documented. Annual cost limit triggers rebate review.
What's Included
- SKILL.md instruction file with framework overview and decision triggers:
- HEOR submission template checklist: identifies 40+ data points to extract from manufacturer dossiers
- Cost-effectiveness validation worksheet: step-by-step model review against payer standards
- Evidence gap assessment framework: systematic comparison methodology checklist
- Coverage recommendation memo template: P&T-ready documentation with evidence grading and rationale fields
- Bias assessment rubric: 12-point methodology audit for common HEOR pitfalls
Who It's For
- Payer HEOR analysts — evaluating manufacturer submissions for coverage decisions
- P&T committee members — reviewing clinical and economic evidence for formulary placement
- Medical directors — validating health economic claims and determining coverage policy
- Pharmacy benefit managers — assessing cost-effectiveness of new drugs and indications
- Market access managers at manufacturers — preparing HEOR dossiers aligned with payer expectations
Best For
- New drug FDA approval HEOR submission evaluation
- Indication expansion and line extension coverage review
- Biosimilar comparative effectiveness dossier analysis
- Annual formulary contract negotiation and rebate justification
- HTA submission counter-evidence preparation for international markets
- Cost-effectiveness threshold validation and willingness-to-pay assessment
- Prior authorization criteria development based on clinical evidence
You might also like
You can rapidly map the clinical, pharmacy, and procurement decision-makers at target hospital systems, assemble persuasive health economic and clinical evidence tailored to each stakeholder's priorities, and develop presentation strategies that address objections before committee meetings occur. This skill compresses typical 6+ month formulary cycles into 2-3 meeting cycles by organizing evidence strategically and anticipating pharmacoeconomic scrutiny.
by killvault
Transform scattered clinical research into structured, evidence-based summaries tailored for healthcare decision-making. This skill automatically assesses study quality, evaluates potential biases, and grades the strength of evidence using standardized frameworks like GRADE. You get synthesis ready to inform clinical decisions, guideline updates, or research protocols—all with transparent reasoning about confidence levels and limitations.
by killvault
This skill automates the complete lifecycle of electronic records—from classification and retention scheduling to audit logging and compliant disposal. You provide record metadata or policy requirements, and Claude generates classification matrices, retention schedules, compliance assessments, and disposal workflows tailored to regulations like GDPR, HIPAA, and SOX. It eliminates manual record management and ensures your organization never misses retention deadlines or violates regulatory holds.
by killvault
Evaluate your collections for preservation risks and generate prioritized, data-driven digitization strategies. This workflow synthesizes conservation assessments, stakeholder perspectives, and collection metadata into a comprehensive prioritization matrix and multi-phase digitization roadmap. You'll get actionable recommendations backed by risk scores and impact assessments.
by killvault
Create professional institutional policies, detailed finding aids, accession records, and collection management documentation tailored to your special collections. You'll produce compliance-ready policies, descriptive guides that improve discoverability, and standardized documentation frameworks that streamline collection administration.
by killvault
Gather competitive intelligence from multiple sources and transform it into structured executive briefings. You'll receive verified, cited analysis that highlights competitive positioning, market threats, and strategic opportunities. The skill organizes findings into polished, decision-ready formats complete with source attribution and actionable insights.
by killvault
This skill helps you design robust metadata schemas for library and archival digitization projects, validate collections against preservation standards like PREMIS and Dublin Core, and create compliance documentation to ensure your digital assets meet long-term preservation requirements. You get detailed gap analysis, preservation risk assessments, and actionable remediation plans for any stage of digitization workflow.
by killvault
You build comprehensive scientific briefs that transform reactive Q&A into proactive narrative leadership. This skill helps you layer evidence from mechanism of action through clinical endpoints to real-world outcomes, while mapping anticipated objections and preparing response frameworks that preserve credibility in high-stakes HCP conversations. You'll structure interactions with key opinion leaders, advisory boards, and research groups with the scientific rigor they expect.
by killvault